Nexus Pharmaceuticals

Executive Summary

Nexus Pharmaceuticals is a US-based, family-owned, minority-led manufacturer specializing in generic and specialty injectable drugs since 2003. The company focuses on first-to-market FDA-approved generics, addressing critical unmet medical needs in cardiovascular, oncology, and other therapeutic categories. With a robust pipeline and a track record of dependable supply, Nexus has positioned itself as a key player in the generic injectable market. The company operates from Lincolnshire, Illinois, and remains privately held.

Upcoming Catalysts (preview)

• Q3 2026FDA approval of a first-to-market generic injectable70% success
• Q4 2026Completion of a new manufacturing facility expansion80% success
• Q1 2027Strategic partnership or licensing agreement for pipeline products50% success